title: Clinical spectrum of cutaneous leishmaniasis: an overview from Pakistan.
abstract: The clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localized (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral). The clinico-pathological picture of cutaneous leishmaniasis is variable and depends not only on the leishmania species but also on endemic region, host factors, and immuno-inflammatory responses. Symptomatic disease is subacute or chronic and diverse in presentation and outcome. Pakistan is one of the countries in which cutaneous leishmaniasis is becoming an epidemic disease and because of its morbidity and disfiguring scars, it is considered a serious public health problem. This is an attempt to review the clinical spectrum of old world cutaneous leishmaniasis, classical and unusual clinical presentations, occurring in Pakistan.
authors.affiliation: Department of Dermatology, CMH, Peshawar, Pakistan.
authors.forename: Arfan Ul
authors.initials: AU
authors.lastname: Bari
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D060085:Coinfection / Q000382:microbiology; D005260:Female; D015658:HIV Infections / Q000382:microbiology; D006801:Humans; D015994:Incidence; D007891:Leishmania / Q000187:drug effects / Q000302:isolation & purification; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology*; D008297:Male; D010154:Pakistan / Q000453:epidemiology
chemical_list: D000981:Antiprotozoal Agents